Who We Are


CMC Pharma’s scientists (BS, MS, PhD) are skilled in developing, testing, and manufacturing pharmaceutical drug products, with extensive industry experience from early phase development to commercial launch. These scientists excel in solving the most demanding technical challenges in drug product development. Our speedy responsiveness, flexibility, and wealth of technical knowledge distinguishes us in meeting your program needs and customizing your experimental requirements.

Mike Radomsky, PhD: President and Co-Founder

Dr. Radomsky is a pharmaceutical industry scientist and executive with nearly 30 years of experience in a broad scope of leadership, technical, regulatory, entrepreneurial, and consulting roles. His expertise results from his PhD in chemical engineering from The Johns Hopkins University and leading the formulation development, manufacturing, and commercialization activities of small molecule, peptide, and protein drugs. Dr. Radomsky focused his early research efforts on the development of using polymers to deliver drugs in a controlled release fashion and completed his dissertation on the use of polymers to deliver antibodies for the prevention and treatment of infectious diseases. Dr. Radomsky has demonstrated success in advancing generic and innovator product pipelines from discovery to launch utilizing a wide variety of resources. By leading large and small groups of cross functional teams, Dr. Radomsky has developed a keen understanding of the unique dynamics between research, development, manufacturing, quality, clinical, and the regulatory functions required to develop and manufacture FDA regulated pharmaceutical products. He is a co-founder of CMC Pharma, and currently President of CMC Pharma serving as Principal Investigator for DoD funded and other research, development, and manufacturing programs.

Don Duwe: Lab Director

Don is a professional scientist who began his pharmaceutical career in 1995 holding several positions throughout from analytical bench chemist to leadership roles. After working in the pharmaceutical industry for over 24 years, he builds quality and integrity into products from early design and conception through commercialization. He is proficient in working with early stage to commercialized drug products; including the development, validation, and transfer of stability indicating analytical methods. He has utilized his extensive knowledge in directing and managing pharmaceutical Quality Control and Quality Assurance functions. Don has performed analytical testing on hundreds of small molecule products from raw material to drug products for human use and participated in the execution of early to late stage development of complex analytical methods. In Quality roles, he was an active member of committees providing direction for the development and sustainability of drug shortage finished dosage products. Don is currently the Lab Director at CMC Pharma responsible for all  laboratory operations and supervision of CMC Pharma chemists.

Lisa A. Losch: Assistant PM and Special Projects Manager

Lisa Losch is a Chemical Engineer with 15+ years of experience in engineering, project management, and operations at manufacturing companies as well as the government and government contractors. Her experience lies in strategizing and leading cross-functional teams to successfully execute complex projects including areas of sourcing, manufacturing, logistics, and cost control. She has exceptional attention to detail and organizational skills. Lisa is currently the Special Projects Manager at CMC Pharma.

Casey Loveland: Business Manager

Casey Loveland has a background in marketing, working primarily in publishing and insurance since graduating with a degree in Communications from the University of San Diego. She transitioned into Pharmaceuticals 4 years ago to assist in the building of CMC Pharma and now involved in the day to day operations of the company. Casey has used her organizational and planning skills to successfully set up and maintain the required licenses, insurances and procedures in order to operate a thriving company. Casey is a co-founder and current business manager at CMC Pharma.

Art Tipton, PHD: Advisor

Art has had leadership roles in three start-ups including as Founder and CEO. With a broad science and business background, Art has particular strength in life sciences. He has 43 patents, numerous publications and his efforts have led to multiple commercial products. He serves on six boards and has previous board experience on 11 additional boards. He has been recognized with numerous awards, including induction into the National Academy of Inventors, the College of Fellows for both the Controlled Release Society and the American Institute for Medical and Biological Engineering. He has a Ph.D. in Polymer Science and Engineering from the University of Massachusetts. Art is currently serving CMC Pharma as an advisor across a number of programs. Most recently, Art was elected to the National Academy of Engineering in 2021.

Mary Kay Delmedico, PHD: Consultant

Mary Kay has dedicated more than 25 years to the biopharmaceutical industry, holding senior executive leadership roles in support of scientific, clinical, regulatory, commercial, and strategic objectives across multiple therapeutic areas, including virology, diabetes, pain, and oncology supportive care. She has been an integral part of product design and development from early discovery, candidate selection, IND-enabling studies, clinical development and commercialization, and is an experienced project leader of multi-functional teams. Mary Kay holds a B.S. from St. Edwards University and a Ph.D. in chemistry from the University of California, Berkeley. She is currently serving CMC Pharma as a consultant.

Clark March: Consultant, Analytical Chemistry SME

Clark March has an MS from Virginia Commonwealth University / Medical College of Virginia and more than 30 years experience in the industry. He has extensive experience with chromatographic method development and validation of bioanalytical and content/impurity/dissolution methods, conducting projects under GLP/GMP conditions, communicating with sponsors and partners, dealing with FDA inspectors during laboratory audits, managing CROs and teaching and training junior scientists. His current role at CMC Pharma is to provide analytical chemistry oversight to all programs to ensure compliance with FDA regulations and expectations.